Noramco, headquartered in Wilmington, Delaware, is a global leader in the production of controlled substances for the pharmaceutical industry, for medicines used to treat attention deficit hyperactivity disorder, pain, addiction, and for abuse-deterrent formulations. We realize our success through a keen focus on commercial and operational excellence as well as continuing strategic growth. Our global footprint includes Athens, GA, Wilmington, DE and Neuhausen, Switzerland. 

Specialists in controlled substance development and manufacturing, Noramco is a partner to the pharmaceutical industry:

– Focusing on  high-purity controlled substances
– Leveraging intellectual property to devise the most efficient routes to APIs
– Providing analytical data, chemical and physical properties, stability studies and regulatory assistance
– Formulation friendly particle size grades and extended technical packages
– Delivering DEA-compliant security and production capacity, from kilos to multi-ton supply
– Supporting world-class supply security of controlled-substances, from schedule I to schedule III

Chemicals

Manufacturing

Pharmaceutical

Noramco™

Noramco™'s headquarters in Wilmington, DE, United States

Alan Majewski

Michael Schultz

Chris Roman

Joseph Marsh

Anthony Ambrosini

Mathew Minardi

Scott Warner

Bill Grubb

Description

People (30)

Alan Majewski

Bill Grubb

Scott Warner

Riad Baroud

Colleen Conner

Zhanqian Yu

Xianfeng Sun

Zhen Yang

Jan Wood

Robbie Smith

Jennifer Peroni

Jonathan Laskos

Alexandra V.

Andrew Pierce

Anthony Smith

Joseph Marsh

Keith Taylor

Anthony Ambrosini

Andrew Caruso

Chris Roman

Kevin Ellis

Emily Crowell Burns

Amber Herman

Jacqueline Harrison

Rachel Jackson

Darryl White

Abby Cavaliere

Katie Coleman

Michael Schultz

Yen le

Jobs